Search results for: Paul Barnsley
Filter search results
Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold
12 January 2013
…cost-per-QALY greater than this threshold. The critique by OHE’s Barnsley et al accepts the premise that NICE’s cost-effectiveness threshold should be set equal to the budget decrease that would cause…
OHE at ISPOR Europe: Posters
13 November 2014
…Ispor do nice_decisions_affect_decisions_in_other_countries from Office of Health Economics Karla Hernandez-Villafuerte, Paul Barnsley, Martina Garau and Nancy Devlin Ispor opportunity costs_sks from Office of Health Economics Sarah Karlsberg Schaffer, Jon…
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
…Feasibility Study Karla Hernández-Villafuerte (OHE), Paul Barnsley (Deloitte, formally OHE), Martina Garau (OHE) and Nancy Devlin (OHE). This poster looks at whether NICE recommendations on the use of…
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
…have on that process. Do NICE Decisions Affect Decisions in Other Countries? A Feasibility Study Karla Hernández-Villafuerte (OHE), Paul Barnsley (Deloitte, formally OHE), Martina Garau (OHE) and Nancy…
Mike Paulden – 2022 Prize Finalist
18 January 2023
Dr Mike Paulden, PhD, is an Associate Professor at the School of Public Health, University of Alberta, Canada. He is a health economist with expertise in the economic evaluation of…
Spotlight on OHE: Beyond QALYs, Managed Entry Agreements, Business Models for Antibiotics, and the UK Market for Medicines.
12 April 2016
…for antibiotics, and economics of the market for medicines Beyond QALYs: A Quantum Leap Forward or a Leap in the Dark? OHE’s Paula Lorgelly took part in the Future of…